Breast cancer is the second most common cancer worldwide.1,2,3,4 Radiation therapy (RT) is proved to be efficient for breast cancer treatment.5,6,7 Breast cancer RT is mainly categorized into whole-breast irradiation (WBI) and partial-breast irradiation (PBI), each consisting of a variety of techniques.6,8 Although the principal goal of breast cancer RT is to damage tumor while sparing normal tissues, superior treatment outcome is hampered by some uncertainties such as organ motion. Target motion imposes a negative impact on breast cancer RT, particularly for the left-sided breast. Organ motion is generally categorized into three types: (1) patient motion, (2) interfractional motion occurring between the fractions, and (3) intrafractional motion referring to all involuntary movements during a treatment fraction. Examples of the latter include respiration cycle, heart beating, muscle relaxation/ tension, bowel, and rectal/bladder filling. As the intrafractional motion follows approximately a systemic pattern in an intrafractional motion always increases the apparent size of the target resulting in a larger irradiated volume. It, in turn, increases secondary cancer risk, as well. Owing to the importance of breast cancer, several techniques are introduced to address the problem of respiratory-induced target movement.9 It should be also noted that for the right-sided breast cancer, the management of target motion is not regular mainly due to the larger distance between the heart and the target compared to the left-sided cases. In contrast to lung RT, few studies are focusing on tumor motion management in breast RT. In addition, the literature about addressing breast tumor motion in particle therapy is also sparse. The problem is more challenging in particle therapy than conventional RT mainly due to stricter accuracy requirements and thus mandates special considerations.10 It should also be noted that this review covers only the external-beam RT techniques for breast cancer. To this end, this literature review aims at providing an overview of current intrafractional target motion management techniques for breast cancer irradiation, highlighting the gaps, and finally presenting future directions in the field of interest.
To conduct a comprehensive literature review, all English full-text records indexed in both Scopus and/or PubMed were searched and considered. The published year was limited between 1990 and 2021 to ensure the inclusion of all recent publications. The following keywords were used: “intrafraction”, “intra-fraction”, “intrafractional”, “intra-fractional”, “breast cancer”, “radiotherapy”, “radiation therapy”, “proton therapy”, “proton beam therapy”, “motion”, “particle therapy”, “and respiration”,“prone”, or “supine”. Four identification, screening, eligibility, and inclusion steps were then followed. The selection criteria were as follows: (1) monitoring intrafractional target motion in breast cancer treatment and (2) irradiating moving target in breast cancer treatment. However, some identified articles were excluded since they were either duplicated or irrelevant. Of them, 106 articles fulfilled the inclusion criteria. No specific additional filter was applied. Moreover, additional 45 original articles, reviews, and books were also considered as they were applicable to breast cancer and/or they provided general information on target motion monitoring and management techniques in RT.
Breast subjects to intrafractional movement caused by both baseline shift and respiration and therefore breast cancer RT is always challenged by target motion.6 Usually, the amount of breast motion ranges from 1 mm to more than 20 mm displacement in some cases.6,11,12,13,14,15 Moreover, studies reported that this motion tends to be non-linear (
A promising solution for intrafractional motion monitoring in the chest wall irradiation and breast cancer RT is optical surface imaging.26 Using three optical cameras and light projectors, the 3D map of a patient’s topography is generated and allows visualization of the patient in any position or gantry angle (Figure 1).27
Surface imaging provides mobile target monitoring in the case of breast irradiation. Surface imaging is characterized by easy utilization and high temporal frequency without further radiation dose to the patient.26 It can be matched with a variety of RT techniques (for example, breath-hold and respiratory gating) to reduce setup uncertainties during delivery, which can lead to a reduction in target margins and nearby sparing. Several studies have shown that surface guidance for intrafractional monitoring was mainly utilized for breast breath-hold RT.28,29 Additional benefits of surface imaging include (1) reducing interfractional setup error, (2) monitoring intrafractional motion, and (3) using less invasive patient fixation than other immobilization techniques, and more comfortability of patient as well.30 However, surface guidance comes with some limitations. The visibility of the patient’s skin surface for surface imaging is essential. Therefore, there is a compromise between surface imaging ability and the degree of immobilization. Also, any obstacle on the skin can lead to impossible reflectivity and restricting the function of surface imaging. An important limitation of surface imaging relevance to target localization is insufficient adaption between the external and internal surfaces. However, in breast cancer RT in which the external surface is the target surface, this problem becomes less important.26 Nonetheless, surface-guided RT (SGRT) technology enables adaptive radiation therapy (ART) in which a motion history related to the patient is applied to perform narrower margins in the next following treatment fractions. Current applications of real-time surface imaging rely on breath-hold, respiratory gating, and tumor tracking deliveries.31
Accessibility of the breast (compared to deep organs such as liver or prostate) and typically shallow-seated targets, facilitate the application of internal markers.32 Additionally, breast motion is well characterized by external markers.33 Internal/external markers result in superior performance compared to the surgical clips in terms of both accuracy and detectability on kilovoltage (kV) images.34 Organ displacement and real-time localization during beam delivery can be directly evaluated by employing external surrogate and/or internal radio-opaque fiducial markers. The fiducial marker tracking technique was first introduced for conventional RT and later for particle therapy.32 Target motion tracking using internal markers is usually combined with more than two fluoroscopic imaging examinations. The fiducial markers are implanted near to or inside of the target. Markers (or surgical clips) are usually made from high-Z material such as gold, platinum, carbon-coated zirconium oxide to be visible in X-ray images.35
Using markers for motion monitoring in breast cancer, Kinoshita
While fiducial markers find a wide range of applications in breast cancer due to the existing well signal correlation between tumor site and marker location, their usage is hampered by (1) the invasive nature of marker implantation, (2) possible displacement of the markers even more than few millimeters for tumor volumes far from the skin, (3) lack of volumetric information about anatomy deformations close to organ-at-risks (OARs), and (4) ionizing radiation imaging needed to localize them. Marker displacement from the implanted place, tumor deformation, and tumefaction of surrounding tissues are common reasons leading to such positional error41,42 Artifacts in computed tomography (CT) images caused by high-Z fiducial markers are also problematic.43 Electromagnetic
transducers/transponders (ET) are alternatives to high-Z internal markers providing continuous real-time 3D localization of the target without radiation imaging.26 The Calypso system detects the fiducial marker location in real-time without X-ray imaging.44 Commonly, three transponders with a variety of resonance frequencies (300-500 kHz) are placed in or close to the tumor. While the implementation techniques for ET are feasible and safe, they cannot be standalone. Several works indicate that interfractional variations of transponder location are significant and therefore hybrid real-time monitoring, for example, real-time tumor tracking is recommended.45,46
4D CT provides a high spatial and temporal resolution image of the thorax region during the planning phase to construct the breathing modeling used for managing respiration-induced motion. In other words, 4D CT enables 4D treatment planning. In 4D CT, the respiration cycle is first monitored by an external indicator such as real-time position management (RPM) system followed by dividing the cycle into several gates. Richter
Chan
Recently, 4D magnetic resonance imaging (MRI) has been used to estimate respiratory motion variations and as a procedure to complement and support 4D CT enabling 4D RT planning and simulation.56 Owing to superior soft-tissue contrast and radiation-free imaging features, MRI allows frequent multiple data acquisitions than CT. Due to limited time resolution associated with true 4D MRI, 2D cine-MRI is suggested.57 Individualization of planning target volume (PTV) margin based on cine MRI data in the simulation seems to be a promising solution for the intrafractional motion problem.58 Respiratory-correlated 4D MRI has attained more interest as an alternative to 4D CT for the measurement of respiratory motion.59 Cai
Oar
Gantry-mounted X-ray imaging refers to those X-ray imaging modalities mounted on the treatment gantry allowing monoscopic and stereoscopic X-ray imaging. Portal imaging using electronic portal imaging devices (EPID) is a popular example of gantry-mounted imaging. Beam’s eye view (BEV) portal imaging also enables real-time target motion tracking. Portal imaging is acquired with the help of the therapeutic megavoltage (MV) beam. Recently, gantry-mounted kV X-ray radiographic/fluoroscopic imaging is also available by either kV X-ray tubes or reduction of linac beam energy from MV to kV ranges.47 The Vero, ExcaTrac, and CyberKnife systems offer stereoscopic imaging using two kV sources coupled with two flat-panel detectors.26
The acquisition of portal imaging is proved to be fast as well as easy to use in order to measure patient movement during breast cancer RT.65 Richer
Rapid imaging along with no ionizing radiation makes ultrasound (US) imaging suitable for estimating intrafractional motion during the planning and simulation phases. The real-time US is also of interest in breast imaging mainly due to the lack of bony structures and also easy accessibility of the organ.26,68 4D US provides almost real-time 3D rendered image data and is considered as a basis of multidimensional imaging of the breast.68 In addition, 3D/4D US of the breast provides diagnostic information of the coronal plane.68
US imaging typically provides good soft-tissue contrast and therefore allows contouring breast tumors. Furthermore, imaging artifact limits the application of real-time US imaging.68,69,70 Because of its manual operation, the image quality is also user-dependent as well.68 Despite well-established applications of US in diagnostics, target delineation, and pre-treatment localization, the use of real-time US imaging for intrafractional motion estimation and mitigation for breast cancer is limited and there is no commercially available system. The only commercial US system is Clarity Autoscan (Elekta) for monitoring intrafractional motion26 that is approved specifically for prostate and/or prostate bed RT. However, Wong
In the previous section, the main motion monitoring techniques of breast target were presented. The next step in the RT workflow is to assist the irradiation of mobile targets with motion monitoring data. Common irradiation approaches addressing the respiration-induced intrafractional motion in breast cancer treatment include breath-hold, respiratory gating, and real-time tumor tracking techniques. The influence of intrafractional target motion is of particular concern in APBI due to high doses per fraction, particularly for target volumes close to inhomogeneities (
Breath-hold techniques refer to the management of target motion from the patient side. The deep-inspiration breath-hold (DIBH) method is a practical and easy-to-use solution for breast cancer RT.6 During inhalation, the diaphragm moves the heart posteriorly and inferiorly away from the breast leading to a potential reduction of both heart and lung toxicities.16 As illustrated in Figures 2 and 3, the major role of DIBH in motion-addressed breast cancer RT is increasing the distance between tumor volume and the heart leading to less dose to the heart and therefore a lower rate of toxicity.74,75,76 DIBH is always linked to the beam gating to repeatedly on and off the irradiation beam based upon the patient respiratory cycle.
The DIBH for breast cancer RT is mostly employed in two manners: (1) moderate DIBH and
(2) voluntary DIBH (vDIBH).76,77 The former is also known as active breathing control (ABC) in the literature.79 ABC uses special devices to control airflow during the respiratory cycle77,78, while in vDIBH the patient is partially freely breathing. A decrease in the mean heart dose and the left artery dose to about 67% and 73%, respectively, is observed when using the ABC for breast cancer RT.76 In addition, the ABC devices allow a reduction in setup uncertainties to less than 2 mm.76 The vDIBH is sometimes used in conjunction with respiratory motion monitoring to capture breath function at certain points in the breathing period. As for the ABC, the vDIBH decreases the time for RT simulation and daily setup.76,79 In contrast to ABC, vDIBH offers more patient comfort while it is also inexpensive.75,79 Recently, the DIBH treatment using volumetric-modulated arc therapy (VMAT) is utilized for a patient with the left-sided breast cancer to irradiate both whole breast and regional node with superior target coverage and good cardiac sparing.80,81
Fassi
An efficient method of dealing with moving targets is to gate the radiation field. Respiratory gating refers to the management of target motion during treatment by rapid beam switching within the breathing cycle synchronized with an internal/ external tracking system. Respiratory gating is usually implemented in two fashions: phase-based and amplitude-based gating. The former is accomplished by defining a set of phases (gates) over a complete breathing cycle. The irradiation beam is on in only one or few gates. In contrast, the latter is performed by setting a threshold value on the amplitude of the respiratory signal. Once the respiration signal falls below the predefined threshold, the irradiation beam is on. In a small gating window, the phase-based gating method can result in missing the tumor caused by interfractional position variations.
In contrast to the DIBH, the patient freely breathes while being irradiated with the therapeutic beam in respiratory-gated RT. Therefore, more patient comfort is obtained with respiratory gating.85,86 Korreman
Respiratory gating results in two clinical benefits: (1) acceptable levels of target dose conformity and (2) OARs/normal tissues sparing. There are, however, several challenges associated with respiratory gating mandating further researches. First, time latency at the gating process has a result in underdosage and overdosage of proximal tissue. Thus, a successful gating process needs to minimize time latency during the gating window. Another challenge is a long treatment time by respiratory gating. The longer treatment time is inconvenient for the patients and can result in respiratory pattern variation, such as shift motion.31 Another noticeable challenge for gated IMRT delivery is an increase in delivery time. The low efficiency of gated IMRT, as a product of the IMRT efficiency (20% to 30%) and the gating duty cycle (20% to 30%), results in a 10 to 25-fold increase in delivery time than conventional CRT treatments.88
To obtain benefits of the respiratory gating method, higher temporal resolution, higher soft-tissue contrast, and lower radiation exposure imaging techniques in the RT planning are mandated.67 In some cases, however, motion occurs within the gate window, called residual motion.88 Therefore, there is always a compromise between the amount of residual motion and the duty cycle to search for optimal gating parameters.89 As heart dose automatically leads to an increase in cardiac mortality90, a key question in respiratory gating is, therefore, the selection of optimal gating window parameters. Many studies have proved that the end of inspiration is optimal in terms of heart and lung tissue sparing in the left-sided breast cancer RT.74,21 While the absolute lung volume irradiated is largest in respiratory-gated breast RT, the relative lung volume is smallest in the inspiration phases. Thus, the inspiration phases are optimal for beam gating in breast cancer RT by providing the longest distance between the breast and heart and also minimizing the lung density.74 Although not implemented yet, respiratory gating based on the data from real-time cine MRI data would be a solution for online motion mitigation.
Real-time tumor tracking is generally performed by either robotic radiosurgery, dynamic multi-leaf collimators (DMLCs), or couch movement.91 Owing to the benefits of stereotactic body RT (SBRT), Cyberknife APBI can be considered as a real-time tumor tracking mitigating the intrafractional respiratory motion.92 Methods like kV/MV radiographic imaging with and without markers, US imaging, portal imaging through EPID, kV/MV imaging are real-time tumor tracking methods. A combination of imaging methods with DMLCs (called dynamic IMRT) results in a solution for real-time tumor tracking.93
In breast cancer RT, real-time tumor tracking results in a substantial reduction in the volume of the heart receiving a high radiation dose.93,94 Continues portal imaging during RT has shown promising results for estimating intrafractional chest wall motion of patients with breast cancer by providing time-resolved visualization of the internal organ from BEV.95 As an estimate, Hijal
MLC tracking has been successfully performed for IMRT and VMAT deliveries to address intrafractional target motion.98,99,100 Dynamic IMRT enables dynamically reshaping the treatment field in the BEV based on the actually recorded target motion.101 Furthermore, real-time tumor tracking with IMRT delivery resulted in better cardiopulmonary sparing and improved target coverage for breast cancer treatment.102,103 While the dynamic IMRT provides a highly conformal dose distribution, it is usually challenged by the interplay effect that occurs in the time between leaf and the target motions. The interplay effect automatically leads to motion artifacts in dose distributions.104,105 Synchronization of real-time tumor tracking based on two sets of fluoroscopy and IMRT delivery is also feasible but at the expense of non-negligible skin surface dose.106 Real-time tumor tracking could also result in a percentage depth dose of 58% (at 5 cm) of the peak dose for long IMRT treatments.26 In SGRT-based tumor tracking, beam-on and beam-off delays might play a role and vary between the SGRT system and beam delivery.26 Smaller PTV margins are usually appropriate for patients with breast cancer who are actively monitored with surface imaging during RT.107 Hamming
However, some concerns associated with real-time tumor tracking are the resource-intensive nature of delivery and also imposing the amount of additional radiation dose.110 According to the Report of AAPM Task Group 75 67, a typical in-room kV cone-beam CT of the chest (commonly used in the case of breast cancer RT) leads to a maximum skin dose of 85.4 mGy. Real-time CBCT breast imaging results in a dose of 2 mGy and 12 mGy per scan for the right- and left-sided breast cancers, respectively.110 Liu
Patient positioning (
Because of a significant decrease in irradiated lung volume and even irradiated heart volume in 87% of all patients with the left-sided breast cancer, the prone position outperforms the supine setup by exhibiting improved dose homogeneity and fewer toxicities. Morrow
Particle therapy offers promising treatment outcomes and efforts have been continued to become a mature method for breast cancer treatment. Particle therapy commonly refers to the use of light/heavy charged particles such as protons, carbon-ions and helium-ions for cancer treatment. While active scanning and intensity-modulated proton therapy (IMPT) have become increasingly used in proton therapy, a great number of clinical researches are still published in passive scattering particle therapy (PSPT).10,118 Compared to photon beam RT, particle beams are more sensitive to in-line geometrical and density changes.32,37,119 It is because of the particle interaction mechanism inside of the body.32 In the monitoring of target motion benefiting from implanted surrogates, the high-Z internal markers can significantly alter dose distribution in particle therapy, and therefore thin (less than 0.5 mm in thickness) and low-Z materials, such as carbon-coated zirconium oxide clips, are preferred.120 The degree of such an impact on charged particle dose distribution depends on the marker material, its position in the treatment field, and its thickness.120 Similarly, Landry
Breath-hold particle therapy is also an intrafractional motion mitigation technique in breast patients. However, in spot scanning beam delivery, the breath-hold technique cannot significantly reduce the heart dose mainly due to the so-called interplay effect.5,6 Respiratory gating is also successfully translated into particle therapy to address the problem of the mobile target in breast cancer treat-
ment.37 Respiratory gating can be considered as a direct solution to the problem of dose degradation due to target motion as well as less dependency on the properties of the irradiation system. Similar to photon beams, respiratory gating for particle therapy faces two major challenges: (1) time latency that leads to over- and underdosage of the tumor and nearby tissues and (2) treatment prolongation that causes respiratory pattern variation.32,122
Intrafractional target motion management in active scanning particle therapy is hampered by the interplay effect. The interplay effect (interplay between intrafractional target motion and the beam spot position) is however approached by a new generation of particle accelerators, called Cyclinacs, enabling 4D spot scanning in particle therapy.123 In a comparative study by Flejmer
Patel
parative study, Mondal
The real-time tumor tracking approach for particle therapy is not well clinically available when compared to advance in-room imaging techniques in conventional photon beam therapy. Since particle therapy is much more sensitive to target motion when compared to conventional photon therapy, a combination of several motion mitigation techniques would be most beneficial.128 Though most studies are centered on WBI, the influence of target size, location, breast size, and breathing cycle period is not well understood in APBI with particle beams. The effectiveness of respiratory gating for intrafractional target motion management for left-sided proton APBI needs to be also investigated. In addition, studies should be conducted to assess the impact of prone
MRI guidance is considered the future of image-guided RT (IGRT).129 Real-time MR imaging is also safe in terms of radiation doses.130 The state-of-the-art MR-linac integration in SBRT can provide tracking of the respiratory motion during the treatment fraction. A present limitation of an integrated MR-RT gantry is the high installation cost that limits its use in clinical practices. Acharya
Nachbar
Artificial intelligence (AI) offers a set of key applications in RT workflow, including image segmentation (target and OAR delineation), image registration, radiomics, treatment response assessment/prediction, and tumor tracking. An interesting study showed that using single radiography, a whole 4D data is feasible to predict tumor movement during the treatment fraction using a deep convolutional neural network (DCNN).135,136 Another role of AI in 4D RT is to create synthetic 4D CT from the 4D MRI dataset in MR-only treatment planning.135 Chen
The rescanning (repainting) approach is proved to be effective in managing motion-induced dose uncertainty in actively scanned particle therapy to address the interplay effect.141 However, some repainting methods mandate monitoring patient breathing to provide respiration parameters like period and rate.142 For large target movements (> 5 mm), a combination of the repainting techniques with, for example, respiratory gating and breath-hold techniques lead to a superior outcome in terms of target dose uniformity. It should be mentioned that repainting techniques do not eliminate the use of safety margins entirely covering the target along with its movement extent. A potential pitfall of the repainting approach is a significant increase in total irradiation time.142,143,144 Figure 6 shows the respiratory-correlated layered repainting method.32 An iso-energy layer is irradiated in the gating window. The gating window is then divided into three portions, and therefore the number of rescanning is three.32 While this method is proposed to be applied for lung cancer, its usefulness and applications in APBI are sparse and mandate extra researches.
The term “robust treatment planning” refers to the incorporation of CTV-to-PTV margins into the optimization function during inverse treatment planning in IMRT techniques. The concept of robust treatment planning for breast cancer IMRT is utilized via RayStation TPS, as the sole TPS supporting robust optimization for IMRT.54,145,146,147 Though, studies are shown that internal margin (IM) cannot be entirely eliminated in robust treatment planning.53 Due to some uncertainties in particle therapy, for example, range uncertainty, the definition of simple PTV in particle therapy is suboptimal. Therefore, the role of robust optimization is to effectively address the tumor motion and uncertainties in RT, particularly in particle therapy.145 Robust planning using VMAT delivery for a moving target in the breast generated clinically acceptable plans and was confirmed by real patient CBCT data.147 Not directly applied for intrafractional motion management, the robust optimization for intensity-modulated proton therapy was used to address residual setup errors.148
FLASH-RT refers to ultra high dose RT with treatment time shorter than 0.1 s enabling excellent intrafractional motion management.149 While maintaining local tumor control, FLASH-RT reduces normal tissue toxicity. Despite few clinical devices with the capability to deliver ultra-high dose rates, a lot of preclinical studies confirm the effectiveness of this paradigm-shifting technique.150 In 2019, the first patient with T-cell lymphoma was successfully treated using FLASH-RT with the superior outcome on normal skin and the tumor.151 Despite some technical challenges ahead, the combination of proton therapy (superior conformity) and FLASH-RT (shorter treatment time) can be a viable option for the treatment of breast cancer considering the intrafractional movements.
In this review, a comprehensive overview of the current and the state-of-the-art intrafractional target motion management in breast cancer RT was presented. Particularly, target motion consideration for particle therapy for breast cancer is highlighted. Several techniques available for monitoring intrafractional target movements such as surface imaging, kV/MV imaging with and without markers, 4D CT, 4D MRI, and the real-time US are discussed. Future perspectives for mitigating intrafractional motion, for example, MR guidance, and FLASH-RT are also highlighted. Almost all of the available remedies are directly applicable to breast cancer, mainly since it is an easily accessible organ. However, the SGRT technique seems to be the dominant motion-managed RT strategy for breast cancer. The problem of intrafractional target motion is more challenging in particle therapy, and therefore further research and development efforts still need to be performed to take the full advantages of the presented methods and to address the open questions in technical and clinical issues related to irradiation of mobile targets seated in the breast.